Managing The Minefield Of Mandatory Clinical Trial Registration
This article was originally published in The Gray Sheet
Executive Summary
As key portions of the government's new device clinical trial registry requirements went into effect last week, Medtronic clinical research director Lisa Griffin Vincent offered advice on complying with some of the thornier aspects of the law
You may also be interested in...
Clinical Trial Sponsors Take Heed: Study Disclosure Rules Are Expanding
The recent update of Title VIII of the Food and Drug Administration Amendments Act of 2007 clarifies the requirements for registering clinical trials and disclosing trial results to US FDA, but many trial sponsors and investigators are still confused about their obligations under these rules, as well as the rules governing clinical trial registration and disclosure abroad. Francine Lane, the VP of global transparency at TrialScope, talked to Medtech Insight about the challenges facing clinical trial sponsors trying to comply with these rules and offered some predictions about how these regulations will likely evolve in the future.
Final Guidance Names Submissions Subject To ClinicalTrials.gov Certification
Final guidance published Jan. 21 provides answers for device companies still confused about how and when they must certify to FDA that they have registered their clinical trials on ClinicalTrials.gov
Final Guidance Names Submissions Subject To ClinicalTrials.gov Certification
Final guidance published Jan. 21 provides answers for device companies still confused about how and when they must certify to FDA that they have registered their clinical trials on ClinicalTrials.gov